濮阳东方医院价格便宜濮阳东方看妇科咨询,濮阳东方医院非常可靠,濮阳东方医院男科治疗早泄评价很高,濮阳东方妇科医院做人流费用多少,濮阳东方医院男科割包皮手术权威,濮阳东方医院看妇科病技术可靠,濮阳东方医院男科治阳痿好

WASHINGTON, May 20 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved Sutent to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or that have spread to other parts of the body.Neuroendocrine tumors found in the pancreas are slow-growing and rare. It is estimated that there are fewer than 1,000 new cases in the United States each year.This is the second new approval by the FDA to treat patients with this disease. On May 5, the agency approved Afinitor."FDA believes it is important to provide cancer patients with as many treatment options as possible," said Richard Pazdur, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "The agency is committed to working with companies to bring innovative new therapies to the market and encourages companies to continue exploring additional uses for approved products."The safety and effectiveness of Sutent was established in a single study of 171 patients with metastatic (late-stage) or locally advanced (disease that could not be removed with surgery) disease who received Sutent or a placebo (sugar pill). The study was designed to measure the length of time a patient lived before their disease spread or worsened (progression-free survival).Results from the study demonstrate that Sutent provided benefit to patients by prolonging the median length of time they lived without the cancer spreading or worsening to 10.2 months compared to 5.4 months for patients who received placebo.In patients treated with Sutent for neuroendocrine pancreatic tumors, the most commonly reported side effects included diarrhea, nausea, vomiting, fatigue, anorexia, high blood pressure, energy loss, stomach pain, changes in hair color, inflammation of the mouth, and a decrease in infection-fighting white blood cells.Sutent is marketed by New York City-based Pfizer.

BEIJING, March 29 (Xinhuanet) -- A new study has found that rejection can literally hurt in the same way as physical pain does, according to media reports Tuesday.Researchers found that intense emotional pain, such as feelings of rejection after a breakup of a relationship, can trigger brain activities similar to when people suffer physical pain.The research findings were published in Tuesday's Proceedings of the National Academy of Sciences.The study followed 40 volunteers who experienced unwanted romantic breakups in the past six months, and the researchers analyzed their brain activity during two "painful" situations.The results showed that the two situations, thinking about the loss of their ex-partner and experiencing mild physical pain similar to holding a very hot coffee cup, caused response in the overlapping parts of the brain."This tells us how serious rejection can be sometimes," said study author Edward E. Smith, director of cognitive neuroscience at Columbia University. Smith added. "Our ultimate goal is to see what kind of therapeutic approach might be useful in relieving the pain of rejection."

BEIJING, Feb. 5 (Xinhua) -- Despite profound changes in the global economy, China's banking industry expects steady growth during the 12th Five-Year Plan (2011-2015), a senior banker said Saturday.China's steady and relatively fast economic growth is expected to lay a solid basis for the development of the commercial banks' main businesses, said Hu Huaibang, chairman of Bank of Communications, the fifth-largest lender.Meanwhile, the transformation of China's economic growth pattern would provide an impetus to the adjustment and optimization of the lenders' businesses, Hu said.Hu predicted businesses, such as consumer credit, asset management and credit cards, would enter a golden era over the next few years, along with the economy's shift to a domestic consumption-driven model from the current export-oriented growth pattern.Also, increases in personal wealth and growing numbers in the middle class would bring huge potential customers and development opportunities to the lenders, Hu said.Further, he urged Chinese banks to improve their services and launch new products to meet diversified demands.

BEIJING, Feb. 14 (Xinhuanet) -- The exchange rate against the US dollar is currently at an appropriate level but could fluctuate in the future, Yi Gang, vice-governor of the central bank and head of the State Administration of Foreign Exchange, said on Sunday."In the future, as markets fluctuate and labor productivity changes, the rate will certainly show some fluctuation," he said at a seminar. Last Thursday, the yuan's central parity rate rose to a record high of 6.5849 against the US dollar, after rising for three consecutive trading days, before declining to 6.5952 on Friday.The yuan has appreciated about 3.6 percent against the dollar since mid-June. A report from the US Treasury said earlier that on an inflation-adjusted basis, the appreciation was even higher, at an annual rate of more than 10 percent.US Federal Reserve Chairman Ben Bernanke said last Wednesday that China's recent measures to control inflation by raising interest rates is "surprising" and urged Beijing to let its currency rise in value.Currently the exchange rate is still underestimated by no more than 10 percent, said Lu Mai, secretary-general of the China Development Research Foundation (CDRF).The resilience of exporters to the rising yuan is stronger than previously estimated, which helps to pave the way for more currency reform to liberalize the yuan, he said.In 2007 and 2008, the Chinese currency rose by 7 percent annually against the US dollar, but China's GDP only declined by 0.28 percentage points, with inflation down by 0.42 points and workers' wages up by 0.07 points, according to CDRF research."The figures showed that progressive currency reform since July 2005 was successful, and the government should accelerate the reform and further free the yuan in the next five years to promote healthy, long-term economic development," Lu said.China should keep the proportion of its trade surplus to GDP within 5 percent, and avoid further increasing its huge foreign exchange reserves to allow the currency to settle at a balanced level, he said.China's foreign reserves rose to a record .85 trillion at the end of last year, an 18.7 percent increase year-on-year, according to statistics from the People's Bank of China, the central bank.Yi said he took note of the CDRF findings, but emphasized that further moves depended on both the domestic and international economic situation and appropriate timing.Lu Feng, an economist at Peking University, said now is the right time to deepen currency reform and let the yuan trade at a higher price as inflation is rising.Analysts have predicted that the yuan will appreciate this year as inflation may see the government opt for a rising yuan to lower the cost of purchasing international commodities.Lian Ping, chief economist at the Bank of Communications, predicted the yuan would rise by 5 to 7 percent in 2011.